Systems Oncology Approach to Optimize Ovarian Cancer Treatment

Recruiting Observational Study
Ovarian Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Observational
Participants needed
500 (estimated)
Sponsor
University of Helsinki · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collec…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with ovarian cancer * Available tumor tissue/blood samples Exclusion Criteria: * Inability to consent to the study
Contacts

Anniina Färkkilä, MD PhD

+358504272060

anniina.farkkila@helsinki.fi

CONTACT